November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Wegovy Lowers BMI in Young Children With Obesity, Clinical Trial Finds

❤️ Conditions & Care 2 min read 👁 6

Results from the STEP Young trial indicate that weekly semaglutide injections significantly reduced body mass index in children aged 6 to 11 with obesity compared to a placebo.

Wegovy Lowers BMI in Young Children With Obesity, Clinical Trial Finds❤️Conditions & Care

Photo: medpagetoday.com

Key points

  • Phase III STEP Young trial evaluated semaglutide in children ages 6 to 11 with obesity.
  • Mean BMI decreased by 13.5% at week 68 in the treatment group compared to a 2.7% increase for placebo.
  • Trial noted slower height velocity in the medication group, though bone age and density were similar.

A phase III clinical trial presented at the ObesityWeek annual meeting and published in the New England Journal of Medicine suggests that the GLP-1 medication semaglutide, marketed as Wegovy, can significantly reduce body mass index in children between the ages of 6 and 11 who have obesity. Led by researchers including Ania Jastreboff of the Yale School of Medicine, the STEP Young trial evaluated 167 children across 48 sites in nine countries over a 104-week period.

At week 68, the group receiving weekly semaglutide experienced a mean BMI decrease of 13.5%, whereas the placebo group saw a 2.7% increase. By the end of the 104-week treatment window, the BMI change remained markedly different, showing a 9.4% reduction for the medication group compared to an 8.4% increase for those taking the placebo. Additionally, nearly a third of the participants in the treatment arm dropped below the obesity threshold by week 104, versus just 2% of the placebo cohort.

While standard obesity management for young children usually relies on lifestyle changes, investigators noted that such interventions often yield modest and temporary results. However, utilizing powerful weight-loss medications in prepubertal patients requires careful monitoring, particularly concerning growth and development. The study recorded slower height velocity and reduced linear growth in the treatment group, though measures of bone age and mineral density were comparable between groups. Researchers emphasized that children with severe obesity face serious long-term health risks and significantly impacted quality of life.

What to know: The double-blind trial involved 167 participants who received either subcutaneous semaglutide or a placebo alongside lifestyle counseling. Readers should consult a qualified healthcare provider before making any personal medical or treatment decisions regarding weight management for children.

Source medpagetoday.com — medpagetoday.com/meetingcoverage/obesityweek/123910 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.